ArticleBMC public health2025
Timely vaccination with valid doses in a high coverage country, Oman.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOman has achieved consistently high national immunization coverage; however, the timeliness and validity of vaccine administration remain under-assessed. This study evaluated the timeliness and validity of routine childhood vaccinations to provide a more comprehensive understanding of immunization program performance.
methodsA cross-sectional survey was conducted using WHO cluster sampling, targeting children under five across all 11 governorates and 61 districts in Oman. Data from 17,501 children were collected using the Epicollect5 app and verified through immunization cards and health records. Descriptive statistics, chi-square tests, and WHO operational definitions were used to assess crude coverage, valid doses, timeliness, and dropout rates.
resultsCrude national vaccination coverage was high (94.4-99.9%), with 98.7% of children fully immunized. However, only 78% received valid vaccinations, indicating missed or delayed doses. Timely vaccination rates decreased with age, with notable delays at 18 months. Invalid vaccination rates ranged from 3.3% at birth to 28.1% at 18 months, with significant district-level variation. Dropout rates slightly increased with age, peaking in Muscat and Dhofar.
conclusionsOman achieves high vaccination coverage; however, a noteworthy number of children receive invalid doses. This highlights the urgent need to educate parents and healthcare providers on timely administration of valid doses. Assessing mild illnesses and promptly administering vaccinations can improve complete vaccination rates with valid doses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.